We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+15.73%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.4B
AUM Growth
+$1.02B
Cap. Flow
-$761M
Cap. Flow %
-6.65%
Top 10 Hldgs %
38.51%
Holding
1,217
New
80
Increased
450
Reduced
355
Closed
36

Top Buys

Rank Stock Value
1
PSA icon
Public Storage
PSA
+$250M
2
EQIX icon
Equinix
EQIX
+$102M
3
EXR icon
Extra Space Storage
EXR
+$63.2M
4
INVH icon
Invitation Homes
INVH
+$48.9M
5
PEB icon
Pebblebrook Hotel Trust
PEB
+$41.9M

Top Sells

Rank Stock Value
1
VNO icon
Vornado Realty Trust
VNO
+$172M
2
CCI icon
Crown Castle
CCI
+$121M
3
DOC icon
Healthpeak Properties
DOC
+$101M
4
VTR icon
Ventas
VTR
+$100M
5
SBAC icon
SBA Communications
SBAC
+$96.7M

Sector Composition

Rank Sector Weight
1 Real Estate 74.34%
2 Technology 3.93%
3 Industrials 3.02%
4 Financials 2.65%
5 Healthcare 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DBC icon
1026
Invesco DB Commodity Index Tracking Fund
DBC
$1.67B
$8K ﹤0.01%
500
– –
INVA icon
1027
Innoviva
INVA
$1.57B
$8K ﹤0.01%
597
– –
TBPH icon
1028
Theravance Biopharma
TBPH
$874M
$8K ﹤0.01%
+353
New +$8.95K
WNS
1029
DELISTED
WNS Holdings
WNS
$8K ﹤0.01%
+150
New +$7.52K
WVE icon
1030
Wave Life Sciences
WVE
$1.14B
$8K ﹤0.01%
213
-24
-10% -$974
SPPI
1031
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$8K ﹤0.01%
706
+150
+27% +$1.61K
CLVS
1032
DELISTED
Clovis Oncology, Inc.
CLVS
$8K ﹤0.01%
336
+65
+24% +$1.63K
APLS
1033
DELISTED
Apellis Pharmaceuticals
APLS
$7K ﹤0.01%
358
-142
-28% -$2.23K
EDIT icon
1034
Editas Medicine
EDIT
$411M
$7K ﹤0.01%
304
+71
+30% +$1.61K
ESPR
1035
DELISTED
Esperion Therapeutics
ESPR
$7K ﹤0.01%
171
+26
+18% +$1.17K
FATE icon
1036
Fate Therapeutics
FATE
$283M
$7K ﹤0.01%
410
-140
-25% -$2.21K
LKFT
1037
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.84B
$7K ﹤0.01%
60
– –
HCM icon
1038
HUTCHMED
HCM
$1.91B
$7K ﹤0.01%
215
-65
-23% -$1.62K
IOVA icon
1039
Iovance Biotherapeutics
IOVA
$2.19B
$7K ﹤0.01%
785
+384
+96% +$3.73K
PACB icon
1040
Pacific Biosciences
PACB
$422M
$7K ﹤0.01%
960
+318
+50% +$2.3K
TXMD icon
1041
TherapeuticsMD
TXMD
$24M
$7K ﹤0.01%
31
+7
+29% +$1.85K
VCYT icon
1042
Veracyte
VCYT
$4.44B
$7K ﹤0.01%
261
+73
+39% +$1.39K
QTTB icon
1043
Q32 Bio
QTTB
$452M
$7K ﹤0.01%
13
-6
-32% -$2.68K
LMNX
1044
DELISTED
Luminex Corp
LMNX
$7K ﹤0.01%
284
+41
+17% +$1.03K
ALDR
1045
DELISTED
Alder Biopharmaceuticals
ALDR
$7K ﹤0.01%
508
+134
+36% +$1.74K
AKBA icon
1046
Akebia Therapeutics
AKBA
$343M
$6K ﹤0.01%
740
+479
+184% +$3.29K
BCRX icon
1047
BioCryst Pharmaceuticals
BCRX
$2.43B
$6K ﹤0.01%
697
+153
+28% +$1.31K
CHRS icon
1048
Coherus Oncology
CHRS
$225M
$6K ﹤0.01%
440
+120
+38% +$1.6K
MGNX icon
1049
MacroGenics
MGNX
$254M
$6K ﹤0.01%
310
+107
+53% +$1.85K
RYTM icon
1050
Rhythm Pharmaceuticals
RYTM
$7.28B
$6K ﹤0.01%
219
-81
-27% -$2.33K
40 41
42
43 44

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q1 2019 Portfolio in Review

As of Q1 2019, Daiwa Securities Group held 1,217 positions worth $11.4B, up 9.8% from $10.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group withdrew a net $761M in Q1 2019, closing 36 positions and reducing 355 holdings. Its most notable exit was CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S, an estimated $15.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 74% of assets, down from 75% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Steris worth $13.7M.

  • Daiwa Securities Group's largest Q1 2019 buy was Steris: 106,969 shares worth $13.7M.
  • Daiwa Securities Group added most to Public Storage in Q1 2019, an estimated $250M increase.
  • Daiwa Securities Group's biggest Q1 2019 reduction was Vornado Realty Trust, cutting an estimated $172M.
  • Daiwa Securities Group fully exited CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S in Q1 2019, selling an estimated $15.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $11.4B portfolio in Q1 2019.
  • Daiwa Securities Group opened 80 new positions and closed 36 in Q1 2019.
  • Daiwa Securities Group's portfolio value rose 9.8% quarter-over-quarter to $11.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2019, filed 26 Apr 2019.